Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain

Autor: Webster, Lynn, Jansen, Jan Peter, Peppin, John, Lasko, Ben, Irving, Gordon, Morlion, Bart, Snidow, Jerry, Pierce, Amy, Mortensen, Eric, Kleoudis, Christi, Carter, Eric
Zdroj: In Pain 2008 137(2):428-440
Databáze: ScienceDirect